|
1
|
American Cancer Society: About colorectal
cancer-overview and types. American Cancer Society, Inc., Atlanta
GA, 2018. urihttps://www.cancer.org/cancer/colon-rectal-cancer/about.htmlsimplehttps://www.cancer.org/cancer/colon-rectal-cancer/about.html.
|
|
2
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sharkas GF, Arqoub KH, Khader YS, Tarawneh
MR, Nimri OF, Al-Zaghal MJ and Subih HS: Colorectal cancer in
Jordan: Survival rate and its related factors. J Oncol.
2017(3180762)2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Calle EE, Thun MJ, Petrelli JM, Rodriguez
C and Heath CW Jr: Body-mass index and mortality in a prospective
cohort of U.S. adults. N Engl J Med. 341:1097–1105. 1999.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hubert HB, Feinleib M, McNamara PM and
Castelli WP: Obesity as an independent risk factor for
cardiovascular disease: A 26-year follow-up of participants in the
Framingham heart study. Circulation. 67:968–77. 1983.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mokdad AH, Ford ES, Bowman BA, Nelson DE,
Engelgau MM, Vinicor F and Marks JS: Diabetes trends in the U.S.:
1990-1998. Diabetes Care. 23:1278–1283. 2000.PubMed/NCBI View Article : Google Scholar
|
|
7
|
World Cancer Research Fund, American
Institute for Cancer Research (AICR): Food, nutrition, physical
activity, and the prevention of cancer: A global perspective. AICR,
Washington, DC, 2007.
|
|
8
|
Ungefroren H, Gieseler F, Fliedner S and
Lehnert H: Obesity and cancer. Horm Mol Biol Clin Investig.
21:5–15. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Colditz GA, Wolin KY and Gehlert S:
Applying what we know to accelerate cancer prevention. Sci Transl
Med. 4(127rv4)2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
American Cancer Society: Body weight and
cancer risk. American Cancer Society, Inc., Atlanta GA, 2015.
urihttps://www.cancer.org/cancer/cancer-causes/diet-physical-activity/body-weight-and-cancer-risk/effects.htmlsimplehttps://www.cancer.org/cancer/cancer-causes/diet-physical-activity/body-weight-and-cancer-risk/effects.html.
|
|
11
|
Bjørge T, Engeland A, Tverdal A and Smith
GD: Body mass index in adolescence in relation to cause-specific
mortality: A follow-up of 230,000 Norwegian adolescents. Am J
Epidemiol. 168:30–37. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
van Kruijsdijk RC, van der Wall E and
Visseren FL: Obesity and cancer: The role of dysfunctional adipose
tissue. Cancer Epidemiol Biomarkers Prev. 18:2569–2578.
2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang Y, Proenca R, Maffei M, Barone M,
Leopold L and Friedman JM: Positional cloning of the mouse obese
gene and its human homologue. Nature. 372:425–432. 1994.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Münzberg H and Myers MG Jr: Molecular and
anatomical determinants of central leptin resistance. Nat Neurosci.
8:566–570. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Hardwick JCH, Van Den Brink GR, Offerhaus
GJ, Van Deventer SJH and Peppelenbosch MP: Leptin is a growth
factor for colonic epithelial cells. Gastroenterology, 2001.
|
|
16
|
Aparicio T, Kotelevets L, Tsocas A,
Laigneau JP, Sobhani I, Chastre E and Lehy T: Leptin stimulates the
proliferation of human colon cancer cells in vitro but does not
promote the growth of colon cancer xenografts in nude mice or
intestinal tumorigenesis in Apc(Min/+) mice. Gut. 54:1136–1145.
2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Samad N and Rao T: Role of leptin in
cancer: A systematic review. Biomed J Sci Tech Res. 18:13226–13235.
2019.
|
|
18
|
Paik SS, Jang SM, Jang KS, Lee KH, Choi D
and Jang SJ: Leptin expression correlates with favorable
clinicopathologic phenotype and better prognosis in colorectal
adenocarcinoma. Ann Surg Oncol. 16:297–303. 2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Koda M, Sulkowska M, Kanczuga-Koda L,
Surmacz E and Sulkowski S: Overexpression of the obesity hormone
leptin in human colorectal cancer. J Clin Pathol. 60:902–906.
2007.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Viengchareun S, Zennaro MC, Pascual-Le
Tallec L and Lombes M: Brown adipocytes are novel sites of
expression and regulation of adiponectin and resistin. FEBS Lett.
532:345–350. 2002.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Beltowski J: Adiponectin and resistin-new
hormones of white adipose tissue. Med Sci Monit. 9:RA55–RA61.
2003.PubMed/NCBI
|
|
22
|
Liu M and Liu F: Regulation of adiponectin
multimerization, signaling and function. Best Pract Res Clin
Endocrinol Metab. 28:25–31. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Aleksandrova K, Jenab M, Bueno-de-Mesquita
HB, Fedirko V, Kaaks R, Lukanova A, van Duijnhoven FJ, Jansen E,
Rinaldi S, Romieu I, et al: Biomarker patterns of inflammatory and
metabolic pathways are associated with risk of colorectal cancer:
Results from the European prospective investigation into cancer and
nutrition (EPIC). Eur J Epidemiol. 29:261–275. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chandran M, Phillips SA, Ciaraldi T and
Henry RR: Adiponectin: More than just another fat cell hormone?
Diabetes Care. 26:2442–2450. 2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Giovannucci E and Michaud D: The role of
obesity and related metabolic disturbances in cancers of the colon,
prostate, and pancreas. Gastroenterology. 132:2208–2225.
2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Catalán V, Gómez-Ambrosi J, Rodríguez A,
Ramírez B, Silva C, Rotellar F, Hernández-Lizoain JL, Baixauli J,
Valentí V, Pardo F, et al: Up-regulation of the novel
proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and
osteopontin as well as angiogenic-related factors in visceral
adipose tissue of patients with colon cancer. J Nutr Biochem.
22:634–641. 2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kemik O, Kemik AS, Begenik H, Erdur FM,
Emre H, Sumer A, Purisa S, Tuzun S and Kotan C: The relationship
among acute-phase responce proteins, cytokines, and hormones in
various gastrointestinal cancer types patients with cachectic. Hum
Exp Toxicol. 31:117–125. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Al Khaldi RM, Al Mulla F, Al Awadhi S,
Kapila K and Mojiminiyi OA: Associations of single nucleotide
polymorphisms in the adiponectin gene with adiponectin levels and
cardio-metabolic risk factors in patients with cancer. Dis Markers.
30:197–212. 2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zekri AR, Bakr YM, Ezzat MM, Zakaria MS
and Elbaz TM: Circulating levels of adipocytokines as potential
biomarkers for early detection of colorectal carcinoma in Egyptian
patients. Asian Pacific J Cancer Prev. 16:6923–6928.
2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
American Joint Committee on Cancer:
Chapter 20-Colon and rectum. In: AJCC cancer staging manual. 8th
edition. Springer, New York, NY, 2017.
|
|
31
|
Dukes CE: The classification of cancer of
the rectum. Dis Colon Rectum. 23:605–611. 1980.
|
|
32
|
Tessitore L, Vizio B, Jenkins O, De
Stefano I, Ritossa C, Argiles JM, Benedetto C and Mussa A: Leptin
expression in colorectal and breast cancer patients. Int J Mol Med.
5:421–426. 2000.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kumor A, Daniel P, Pietruczuk M and
Małecka-Panas E: Serum leptin, adiponectin, and resistin
concentration in colorectal adenoma and carcinoma (CC) patients.
Int J Colorectal Dis. 24:275–281. 2009.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Sălăgeanu A, Tucureanu C, Lerescu L, Caras
I, Pitica R, Gangurà G, Costea R and Neagu S: Serum levels of
adipokines resistin and leptin in patients with colon cancer. J Med
Life. 3:416–420. 2010.PubMed/NCBI
|
|
35
|
Ho GYF, Wang T, Gunter MJ, Strickler HD,
Cushman M, Kaplan RC, Wassertheil-Smoller S, Xue X, Rajpathak SN,
Chlebowski RT, et al: Adipokines linking obesity with colorectal
cancer risk in postmenopausal women. Cancer Res. 72:3029–3037.
2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kim HR: Obesity-related colorectal cancer:
The role of leptin. Ann Coloproctol. 31:209–210. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Hellström L, Wahrenberg H, Hruska K,
Reynisdottir S and Arner P: Mechanisms behind gender differences in
circulating leptin levels. J Intern Med. 247:457–462.
2000.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Saad MF, Damani S, Gingerich RL,
Riad-Gabriel MG, Khan A, Boyadjian R, Jinagouda SD, el-Tawil K,
Rude RK and Kamdar V: Sexual dimorphism in plasma leptin
concentration. J Clin Endocrinol Metab. 82:579–584. 1997.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Licinio J, Negrão AB, Mantzoros C,
Kaklamani V, Wong ML, Bongiorno PB, Negro PP, Mulla A, Veldhuis JD,
Cearnal L, et al: Sex differences in circulating human leptin pulse
amplitude: Clinical implications. J Clin Endocrinol Metab.
83:4140–4147. 1998.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Lu W, Huang Z, Li N and Liu H: Low
circulating total adiponectin, especially its non-high-molecular
weight fraction, represents a promising risk factor for colorectal
cancer: A meta-analysis. Onco Targets Ther. 11:2519–2531.
2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Rossi S, Basso M, Strippoli A, Schinzari
G, D'Argento E, Larocca M, Cassano A and Barone C: Are markers of
systemic inflammation good prognostic indicators in colorectal
cancer? Clin Colorectal Cancer. 16:264–274. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Słomian G, Świętochowska E, Nowak G,
Pawlas K, Żelazko A and Nowak P: Chemotherapy and plasma adipokines
level in patients with colorectal cancer. Postepy Hig Med Dosw
(Online). 71:281–290. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Seker MM, Sancakdar E, Nadir A, Altun G,
Bahceci A, Kacan T, Babacan NA and Kaptanoglu M: Serum leptin and
adiponectin levels and relationship with prognosis in lung cancer.
J Clin Oncol. 32 (15 Suppl)(e19114)2014.
|
|
44
|
Moschovi M, Trimis G, Vounatsou M,
Katsibardi K, Margeli A, Damianos A, Chrousos G and Papassotiriou
I: Serial plasma concentrations of adiponectin, leptin, and
resistin during therapy in children with acute lymphoblastic
leukemia. J Pediatr Hematol Oncol. 32:e8–e13. 2010.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Ayoub N, Alkhatatbeh M, Jibreel M and
Ababneh M: Analysis of circulating adipokines in patients newly
diagnosed with solid cancer: Associations with measures of
adiposity and tumor characteristics. Oncol Lett. 13:1974–1982.
2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Carvajal-Carmona LG, Spain S, CORGI
Consortium, Kerr D, Houlston R, Cazier JB and Tomlinson I: Common
variation at the adiponectin locus is not associated with
colorectal cancer risk in the UK. Hum Mol Genet. 18:1889–1892.
2009.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Partida-Pérez M, de la Luz Ayala-Madrigal
M, Peregrina-Sandoval J, Macías-Gómez N, Moreno-Ortiz J,
Leal-Ugarte E, Cárdenas-Meza M, Centeno-Flores M, Maciel-Gutiérrez
V, Cabrales E, et al: Association of LEP and ADIPOQ common variants
with colorectal cancer in Mexican patients. Cancer Biomark.
7:117–121. 2010.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Slattery ML, Wolff RK, Herrick J, Caan BJ
and Potter JD: Leptin and leptin receptor genotypes and colon
cancer: Gene-gene and gene-lifestyle interactions. Int J Cancer.
122:1611–1617. 2008.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Yang X, Li J, Cai W, Yang Q, Lu Z, Yu J,
Yu H, Zhang N, Sun D, Qu Y, et al: Adiponectin gene polymorphisms
are associated with increased risk of colorectal cancer. Med Sci
Monit. 21:2595–606. 2015.PubMed/NCBI View Article : Google Scholar
|
